Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Vaccines

Free Subscription 22.10.2018 1 AIDS 1 Clin Infect Dis 2 Lancet 1 N Engl J Med 1 Pediatr Infect Dis J 20 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AIDS

1. PALICH R, Ghosn J, Chaillon A, Boilet V, et al
   Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial.
   AIDS. 2018 Oct 15. doi: 10.1097/QAD.0000000000002058.
   PubMed     Text format     Abstract available
   
   

   
   Clin Infect Dis

2. SMITS G, Stabell Benn C, Whittle H, van Binnendijk R, et al
   Maternal measles antibodies and their influence on all-cause mortality following measles vaccination: an alternative to measure very low maternal antibody levels.
   Clin Infect Dis. 2018 Oct 16. pii: 5133427. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Lancet

3. MARKS F, Kim JH, Rakotozandrindrainy R
   Madagascar should introduce typhoid conjugate vaccines now.
   Lancet. 2018;392:1309-1310.
   PubMed     Text format    
   
   
4. THE LANCET
   Preparing for seasonal influenza.
   Lancet. 2018;391:180.
   PubMed     Text format    
   
   

   
   N Engl J Med

5. ANDREWS JR, Qamar FN, Charles RC, Ryan ET, et al
   Extensively Drug-Resistant Typhoid - Are Conjugate Vaccines Arriving Just in Time?
   N Engl J Med. 2018;379:1493-1495.
   PubMed     Text format    
   
   

   
   Pediatr Infect Dis J

6. CLAEYS C, Chandrasekaran V, Garcia-Sicilia J, Prymula R, et al
   Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naive Children.
   Pediatr Infect Dis J. 2018 Oct 15. doi: 10.1097/INF.0000000000002217.
   PubMed     Text format     Abstract available
   
   

   
   Vaccine

7. BOCKSTAL V, Tiemessen MM, Achterberg R, Van Wordragen C, et al
   An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6(R) cell culture platform is immunogenic and safe in a non-human primate model.
   Vaccine. 2018 Oct 9. pii: S0264-410X(18)31349.
   PubMed     Text format     Abstract available
   
   
8. LIU W, Wong YC, Chen SMY, Tang J, et al
   DNA prime/MVTT boost regimen with HIV-1 mosaic Gag enhances the potency of antigen-specific immune responses.
   Vaccine. 2018 Jun 28. pii: S0264-410X(18)30888.
   PubMed     Text format     Abstract available
   
   
9. BOUKHVALOVA MS, Mbaye A, Kovtun S, Yim KC, et al
   Improving ability of RSV microneutralization assay to detect G-specific and cross-reactive neutralizing antibodies through immortalized cell line selection.
   Vaccine. 2018;36:4657-4662.
   PubMed     Text format     Abstract available
   
   
10. PENNINGTON SH, Ferreira DM, Reine J, Nyirenda TS, et al
    Longevity of duodenal and peripheral T-cell and humoral responses to live-attenuated Salmonella Typhi strain Ty21a.
    Vaccine. 2018;36:4725-4733.
    PubMed     Text format     Abstract available
    
    
11. YEZLI S, Gautret P, Assiri AM, Gessner BD, et al
    Prevention of meningococcal disease at mass gatherings: Lessons from the Hajj and Umrah.
    Vaccine. 2018;36:4603-4609.
    PubMed     Text format     Abstract available
    
    
12. ALQAHTANI AS, Tashani M, Ridda I, Gamil A, et al
    Burden of clinical infections due to S. pneumoniae during Hajj: A systematic review.
    Vaccine. 2018;36:4440-4446.
    PubMed     Text format     Abstract available
    
    
13. MACINTYRE CR, Kpozehouen E, Kunasekaran M, Harriman K, et al
    Measles control in Australia - threats, opportunities and future needs.
    Vaccine. 2018;36:4393-4398.
    PubMed     Text format     Abstract available
    
    
14. MAKARKOV AI, Patel AR, Bainov V, Ward BJ, et al
    A novel serological assay for influenza based on DiD fluorescence dequenching that is free from observer bias and potentially automatable - A proof of concept study.
    Vaccine. 2018;36:4485-4493.
    PubMed     Text format     Abstract available
    
    
15. SCHAEFERS MM, Duan B, Mizrahi B, Lu R, et al
    PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia.
    Vaccine. 2018 Oct 9. pii: S0264-410X(18)31362.
    PubMed     Text format     Abstract available
    
    
16. ODEVALL L, Hong D, Digilio L, Sahastrabuddhe S, et al
    The Euvichol story - Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships.
    Vaccine. 2018 Oct 9. pii: S0264-410X(18)31276.
    PubMed     Text format     Abstract available
    
    
17. GILCA V, Sauvageau C, Panicker G, De Serres G, et al
    Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine - A randomized clinical trial.
    Vaccine. 2018 Oct 9. pii: S0264-410X(18)31326.
    PubMed     Text format     Abstract available
    
    
18. TOKARS JI, Rolfes MA, Foppa IM, Reed C, et al
    An evaluation and update of methods for estimating the number of influenza cases averted by vaccination in the United States.
    Vaccine. 2018 Oct 13. pii: S0264-410X(18)31392.
    PubMed     Text format     Abstract available
    
    
19. BARRERA J, Brake DA, Schutta C, Ettyreddy D, et al
    Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
    Vaccine. 2018 Oct 13. pii: S0264-410X(18)31397.
    PubMed     Text format     Abstract available
    
    
20. NUGENT G, Yockney IJ, Cross ML, Buddle BM, et al
    Low-dose BCG vaccination protects free-ranging cattle against naturally-acquired bovine tuberculosis.
    Vaccine. 2018 Oct 13. pii: S0264-410X(18)31391.
    PubMed     Text format     Abstract available
    
    
21. YEOLEKAR LR, Ganguly M, Tyagi P, Ingle NB, et al
    Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
    Vaccine. 2018 Oct 12. pii: S0264-410X(18)31354.
    PubMed     Text format     Abstract available
    
    
22. GERRETSEN HE, Capone S, Vitelli A, Reyes LS, et al
    Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection.
    Vaccine. 2018 Oct 11. pii: S0264-410X(18)31351.
    PubMed     Text format     Abstract available
    
    
23. SASAKI E, Momose H, Hiradate Y, Mizukami T, et al
    Establishment of a novel safety assessment method for vaccine adjuvant development.
    Vaccine. 2018 Oct 11. pii: S0264-410X(18)31361.
    PubMed     Text format     Abstract available
    
    
24. PIRCON JY, Talarico CA, Bollaerts K, Hausdorff WP, et al
    The choice of analytical methodology can alter conclusions regarding herd effects of paediatric pneumococcal vaccination programmes.
    Vaccine. 2018 Oct 10. pii: S0264-410X(18)31355.
    PubMed     Text format     Abstract available
    
    
25. ZHANG Z, Dong Z, Wang Q, Carr MJ, et al
    Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice.
    Vaccine. 2018 Oct 10. pii: S0264-410X(18)31350.
    PubMed     Text format     Abstract available
    
    
26. PUSHKO P, Tretyakova I, Hidajat R, Sun X, et al
    Multi-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactone.
    Vaccine. 2018;36:4346-4353.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: